These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 38214842)

  • 1. Association Between Diverse Cell Death Patterns Related Gene Signature and Prognosis, Drug Sensitivity, and Immune Microenvironment in Glioblastoma.
    Li J; Song Z; Chen Z; Gu J; Cai Y; Zhang L; Wang Z
    J Mol Neurosci; 2024 Jan; 74(1):10. PubMed ID: 38214842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leveraging diverse cell-death patterns to predict the prognosis and drug sensitivity of triple-negative breast cancer patients after surgery.
    Zou Y; Xie J; Zheng S; Liu W; Tang Y; Tian W; Deng X; Wu L; Zhang Y; Wong CW; Tan D; Liu Q; Xie X
    Int J Surg; 2022 Nov; 107():106936. PubMed ID: 36341760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular subtypes of lung adenocarcinoma patients for prognosis and therapeutic response prediction with machine learning on 13 programmed cell death patterns.
    Wei Q; Jiang X; Miao X; Zhang Y; Chen F; Zhang P
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):11351-11368. PubMed ID: 37378675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Machine learning-based biomarker screening for acute myeloid leukemia prognosis and therapy from diverse cell-death patterns.
    Qin Y; Pu X; Hu D; Yang M
    Sci Rep; 2024 Aug; 14(1):17874. PubMed ID: 39090256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic analysis based on the cuproptosis-related genes identifies ferredoxin 1 as an immune regulator and therapeutic target for glioblastoma.
    Dai L; Zhou P; Lyu L; Jiang S
    BMC Cancer; 2023 Dec; 23(1):1249. PubMed ID: 38114959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value and immune relevancy of a combined autophagy-, apoptosis- and necrosis-related gene signature in glioblastoma.
    Bi Y; Wu ZH; Cao F
    BMC Cancer; 2022 Mar; 22(1):233. PubMed ID: 35241019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of clinical prognosis and drug sensitivity in hepatocellular carcinoma through the combination of multiple cell death pathways.
    Chen Q; Zhang C; Meng T; Yang K; Hu Q; Tong Z; Wang X
    Cell Biol Int; 2024 Dec; 48(12):1816-1835. PubMed ID: 39192561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation a prognostic model based on natural killer T cells marker genes for predicting prognosis and characterizing immune status in glioblastoma through integrated analysis of single-cell and bulk RNA sequencing.
    Hu J; Xu L; Fu W; Sun Y; Wang N; Zhang J; Yang C; Zhang X; Zhou Y; Wang R; Zhang H; Mou R; Du X; Li X; Hu S; Xie R
    Funct Integr Genomics; 2023 Aug; 23(3):286. PubMed ID: 37650991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic identification, development, and validation of prognostic biomarkers involving the tumor-immune microenvironment for glioblastoma.
    Zhao B; Wang Y; Wang Y; Chen W; Liu PH; Kong Z; Dai C; Wang Y; Ma W
    J Cell Physiol; 2021 Jan; 236(1):507-522. PubMed ID: 32572951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Constructing a Prognostic Model of Uterine Corpus Endometrial Carcinoma and Predicting Drug-Sensitivity Responses Using Programmed Cell Death-Related Pathways.
    Meng J; Zong C; Wang M; Chen Y; Zhao S
    J Cancer; 2024; 15(10):2948-2959. PubMed ID: 38706893
    [No Abstract]   [Full Text] [Related]  

  • 11. A novel signature based on twelve programmed cell death patterns to predict the prognosis of lung adenocarcinoma.
    Yu SK; Yang J; Zhang Q; Yu T; Lu KH
    Am J Transl Res; 2024; 16(5):2082-2102. PubMed ID: 38883377
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Liang L; Yan B; Liu Y; Jiang S; He H; Huang J; Liu W; Xie L
    Dis Markers; 2022; 2022():4534080. PubMed ID: 35401877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrative analysis of multiple cell death model for precise prognosis and drug response prediction in gastric cancer.
    Su W; Shi X; Wen X; Li X; Zhou J; Zhou Y; Ren F; Kang K
    Discov Oncol; 2024 Oct; 15(1):532. PubMed ID: 39377861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction and validation of a cuproptosis-related prognostic model for glioblastoma.
    Zhang B; Xie L; Liu J; Liu A; He M
    Front Immunol; 2023; 14():1082974. PubMed ID: 36814929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined bulk RNA-seq and single-cell RNA-seq identifies a necroptosis-related prognostic signature associated with inhibitory immune microenvironment in glioma.
    Wan S; Moure UAE; Liu R; Liu C; Wang K; Deng L; Liang P; Cui H
    Front Immunol; 2022; 13():1013094. PubMed ID: 36466844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel risk signature with 6 RNA binding proteins for prognosis prediction in patients with glioblastoma.
    Huang QR; Li JW; Pan XB
    Medicine (Baltimore); 2021 Dec; 100(48):e28065. PubMed ID: 35049227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and analysis of diverse cell death patterns in diabetic kidney disease using microarray-based transcriptome profiling and single-nucleus RNA sequencing.
    Luo Y; Liu L; Zhang C
    Comput Biol Med; 2024 Feb; 169():107780. PubMed ID: 38104515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leveraging diverse cell-death patterns to predict the clinical outcome of immune checkpoint therapy in lung adenocarcinoma: Based on muti-omics analysis and vitro assay.
    Liang H; Li Y; Qu Y; Zhang L
    Oncol Res; 2023; 32(2):393-407. PubMed ID: 38186574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Necroptosis-related Molecular Subtypes and Construction of Necroptosis-related Gene Signature for Glioblastoma Multiforme.
    Li Z; Jin Y; Que T; Zhang XA; Yi G; Zheng H; Yuan X; Wang X; Xu H; Nan J; Chen C; Wu Y; Huang G
    Curr Med Chem; 2024; 31(33):5417-5431. PubMed ID: 37539935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tetraspanins predict the prognosis and characterize the tumor immune microenvironment of glioblastoma.
    Li YC; Wu Y; Chen G; Zhu LZ; Luo X; Nie QQ; Zhang L; Zuo CJ
    Sci Rep; 2023 Aug; 13(1):13317. PubMed ID: 37587203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.